Dr. Slamon's latest paper on a new drug against ER+,her2+ bc

[Lani]

which is synergistic with tamoxifen and/or herceptin when used against breast cancer cell lines (ie, still basic research) with implications for her2+ brain mets and herceptin resistance.

full article is free to all

http://breast-cancer-research.com/content/pdf/bcr2419.pdf

[Jackie07]

Thanks, Lani. This gives so much more hope for us ER+, Her2 + gals.

[schoolteacher]

Thanks Lani,

Amelia

[Unregistered]

Hmmmmmmmmmmmmmmm anybody heard about this drug NOW?

[Jackie07]

There's a clinical trial of the drug currently recruiting participants:

http://clinicaltrials.gov/ct2/show/NCT00721409

[Unregistered]

That said

Inclusion Criteria:

* Inoperable estrogen receptor positive and HER2 negative breast cancer.

[Jackie07]

Sorry. There's another clinical trial that does include Her2+ patients and is currently recruiting:

http://clinicaltrials.gov/ct2/show/NCT01037790?term=PD+0332991&rank=6

[Jean]

Lani,
you are just wonderful....always on the target with the latest reports. This is exciting news...

Thanks,
Jean

[tricia keegan]

Thanks for the info Lani!!